InMode price target lowered to $27 from $29 at Barclays — Oct 13th, 2024

Barclays analyst Matt Miksic lowered the firm’s price target on InMode to $27 from $29 and keeps an Overweight rating on the shares. The company’s preliminary Q3 sales were above consensus on a pro forma basis, “importantly clearing back-orders of new products,” the analyst tells i...

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy — Oct 1st, 2024

YOKNEAM, Israel, Oct. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024. His departure follows that of Dr. Spero Theodorou...

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy — Oct 1st, 2024

YOKNEAM, Israel, Oct. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024. His departure follows that of Dr. Spero Theodorou...

InMode Ltd.'s (NASDAQ:INMD) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason? — Oct 1st, 2024

InMode's (NASDAQ:INMD) stock is up by 3.3% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, we decided to study InMode's ROE in this article. Return on equity or ROE is an important factor ...

InMode Ltd.'s (NASDAQ:INMD) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason? — Oct 1st, 2024

InMode's (NASDAQ:INMD) stock is up by 3.3% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, we decided to study InMode's ROE in this article. Return on equity or ROE is an important factor ...

Is InMode (INMD) a Great Value Stock Right Now? — Oct 14th, 2024

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. Looking at t...

InMode price target lowered to $27 from $29 at Barclays — Oct 13th, 2024

Barclays analyst Matt Miksic lowered the firm’s price target on InMode to $27 from $29 and keeps an Overweight rating on the shares. The company’s preliminary Q3 sales were above consensus on a pro forma basis, “importantly clearing back-orders of new products,” the analyst tells i...

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 — Oct 10th, 2024

Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time YOKNEAM, ...

InMode Ltd.'s (NASDAQ:INMD) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason? — Oct 1st, 2024

InMode's (NASDAQ:INMD) stock is up by 3.3% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, we decided to study InMode's ROE in this article. Return on equity or ROE is an important factor ...

InMode price target lowered to $27 from $29 at Barclays — Oct 13th, 2024

Barclays analyst Matt Miksic lowered the firm’s price target on InMode to $27 from $29 and keeps an Overweight rating on the shares. The company’s preliminary Q3 sales were above consensus on a pro forma basis, “importantly clearing back-orders of new products,” the analyst tells i...

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 — Oct 10th, 2024

Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time YOKNEAM, ...

Is InMode (INMD) a Great Value Stock Right Now? — Oct 14th, 2024

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. Looking at t...

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 — Oct 10th, 2024

Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time YOKNEAM, ...

InMode Ltd.'s (NASDAQ:INMD) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason? — Oct 1st, 2024

InMode's (NASDAQ:INMD) stock is up by 3.3% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, we decided to study InMode's ROE in this article. Return on equity or ROE is an important factor ...

Is InMode (INMD) a Great Value Stock Right Now? — Oct 14th, 2024

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. Looking at t...

Is InMode (INMD) a Great Value Stock Right Now? — Oct 14th, 2024

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. Looking at t...

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 — Oct 10th, 2024

Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time YOKNEAM, ...

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy — Oct 1st, 2024

YOKNEAM, Israel, Oct. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024. His departure follows that of Dr. Spero Theodorou...

InMode price target lowered to $27 from $29 at Barclays — Oct 13th, 2024

Barclays analyst Matt Miksic lowered the firm’s price target on InMode to $27 from $29 and keeps an Overweight rating on the shares. The company’s preliminary Q3 sales were above consensus on a pro forma basis, “importantly clearing back-orders of new products,” the analyst tells i...

InMode Ltd (INMD) Q2 2024 Earnings Call Highlights: Navigating Challenges with New Innovations — Oct 9th, 2024

Total Revenue: $86.4 million in Q2 2024; pro forma revenue was $102.6 million. GAAP Gross Margin: 80% in Q2 2024. Non-GAAP Gross Margin: 81% in Q2 2024; pro forma gross margin was 82%. International Sales: $40.9 million, representing 47% of total sales, a 17% decrease year-over-year. GAAP ...

InMode Ltd.'s (NASDAQ:INMD) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason? — Oct 1st, 2024

InMode's (NASDAQ:INMD) stock is up by 3.3% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, we decided to study InMode's ROE in this article. Return on equity or ROE is an important factor ...

InMode price target lowered to $27 from $29 at Barclays — Oct 13th, 2024

Barclays analyst Matt Miksic lowered the firm’s price target on InMode to $27 from $29 and keeps an Overweight rating on the shares. The company’s preliminary Q3 sales were above consensus on a pro forma basis, “importantly clearing back-orders of new products,” the analyst tells i...

InMode price target lowered to $27 from $29 at Barclays — Oct 13th, 2024

Barclays analyst Matt Miksic lowered the firm’s price target on InMode to $27 from $29 and keeps an Overweight rating on the shares. The company’s preliminary Q3 sales were above consensus on a pro forma basis, “importantly clearing back-orders of new products,” the analyst tells i...

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy — Oct 1st, 2024

YOKNEAM, Israel, Oct. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024. His departure follows that of Dr. Spero Theodorou...

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy — Oct 1st, 2024

YOKNEAM, Israel, Oct. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024. His departure follows that of Dr. Spero Theodorou...

InMode Ltd.'s (NASDAQ:INMD) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason? — Oct 1st, 2024

InMode's (NASDAQ:INMD) stock is up by 3.3% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, we decided to study InMode's ROE in this article. Return on equity or ROE is an important factor ...

InMode Ltd (INMD) Q2 2024 Earnings Call Highlights: Navigating Challenges with New Innovations — Oct 9th, 2024

Total Revenue: $86.4 million in Q2 2024; pro forma revenue was $102.6 million. GAAP Gross Margin: 80% in Q2 2024. Non-GAAP Gross Margin: 81% in Q2 2024; pro forma gross margin was 82%. International Sales: $40.9 million, representing 47% of total sales, a 17% decrease year-over-year. GAAP ...

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 — Oct 10th, 2024

Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time YOKNEAM, ...

InMode Ltd (INMD) Q2 2024 Earnings Call Highlights: Navigating Challenges with New Innovations — Oct 9th, 2024

Total Revenue: $86.4 million in Q2 2024; pro forma revenue was $102.6 million. GAAP Gross Margin: 80% in Q2 2024. Non-GAAP Gross Margin: 81% in Q2 2024; pro forma gross margin was 82%. International Sales: $40.9 million, representing 47% of total sales, a 17% decrease year-over-year. GAAP ...

Should Value Investors Buy InMode (INMD) Stock? — Sep 26th, 2024

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and m...

InMode Ltd (INMD) Q2 2024 Earnings Call Highlights: Navigating Challenges with New Innovations — Oct 9th, 2024

Total Revenue: $86.4 million in Q2 2024; pro forma revenue was $102.6 million. GAAP Gross Margin: 80% in Q2 2024. Non-GAAP Gross Margin: 81% in Q2 2024; pro forma gross margin was 82%. International Sales: $40.9 million, representing 47% of total sales, a 17% decrease year-over-year. GAAP ...

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 — Oct 10th, 2024

Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time YOKNEAM, ...

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 — Oct 10th, 2024

Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time YOKNEAM, ...

Is InMode (INMD) a Great Value Stock Right Now? — Oct 14th, 2024

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. Looking at t...

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy — Oct 1st, 2024

YOKNEAM, Israel, Oct. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024. His departure follows that of Dr. Spero Theodorou...

InMode Ltd (INMD) Q2 2024 Earnings Call Highlights: Navigating Challenges with New Innovations — Oct 9th, 2024

Total Revenue: $86.4 million in Q2 2024; pro forma revenue was $102.6 million. GAAP Gross Margin: 80% in Q2 2024. Non-GAAP Gross Margin: 81% in Q2 2024; pro forma gross margin was 82%. International Sales: $40.9 million, representing 47% of total sales, a 17% decrease year-over-year. GAAP ...

InMode Ltd (INMD) Q2 2024 Earnings Call Highlights: Navigating Challenges with New Innovations — Oct 9th, 2024

Total Revenue: $86.4 million in Q2 2024; pro forma revenue was $102.6 million. GAAP Gross Margin: 80% in Q2 2024. Non-GAAP Gross Margin: 81% in Q2 2024; pro forma gross margin was 82%. International Sales: $40.9 million, representing 47% of total sales, a 17% decrease year-over-year. GAAP ...

Is InMode (INMD) a Great Value Stock Right Now? — Oct 14th, 2024

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. Looking at t...

InMode Ltd (INMD) Q2 2024 Earnings Call Highlights: Navigating Challenges with New Innovations — Oct 9th, 2024

Total Revenue: $86.4 million in Q2 2024; pro forma revenue was $102.6 million. GAAP Gross Margin: 80% in Q2 2024. Non-GAAP Gross Margin: 81% in Q2 2024; pro forma gross margin was 82%. International Sales: $40.9 million, representing 47% of total sales, a 17% decrease year-over-year. GAAP ...

Should Value Investors Buy InMode (INMD) Stock? — Sep 26th, 2024

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and m...

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy — Oct 1st, 2024

YOKNEAM, Israel, Oct. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024. His departure follows that of Dr. Spero Theodorou...

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy — Oct 1st, 2024

YOKNEAM, Israel, Oct. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024. His departure follows that of Dr. Spero Theodorou...

InMode Ltd.'s (NASDAQ:INMD) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason? — Oct 1st, 2024

InMode's (NASDAQ:INMD) stock is up by 3.3% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, we decided to study InMode's ROE in this article. Return on equity or ROE is an important factor ...

Is InMode (INMD) a Great Value Stock Right Now? — Oct 14th, 2024

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. Looking at t...

InMode Ltd (INMD) Q2 2024 Earnings Call Highlights: Navigating Challenges with New Innovations — Oct 9th, 2024

Total Revenue: $86.4 million in Q2 2024; pro forma revenue was $102.6 million. GAAP Gross Margin: 80% in Q2 2024. Non-GAAP Gross Margin: 81% in Q2 2024; pro forma gross margin was 82%. International Sales: $40.9 million, representing 47% of total sales, a 17% decrease year-over-year. GAAP ...

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 — Oct 10th, 2024

Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time YOKNEAM, ...

InMode Ltd.'s (NASDAQ:INMD) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason? — Oct 1st, 2024

InMode's (NASDAQ:INMD) stock is up by 3.3% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, we decided to study InMode's ROE in this article. Return on equity or ROE is an important factor ...

InMode price target lowered to $27 from $29 at Barclays — Oct 13th, 2024

Barclays analyst Matt Miksic lowered the firm’s price target on InMode to $27 from $29 and keeps an Overweight rating on the shares. The company’s preliminary Q3 sales were above consensus on a pro forma basis, “importantly clearing back-orders of new products,” the analyst tells i...

InMode price target lowered to $27 from $29 at Barclays — Oct 13th, 2024

Barclays analyst Matt Miksic lowered the firm’s price target on InMode to $27 from $29 and keeps an Overweight rating on the shares. The company’s preliminary Q3 sales were above consensus on a pro forma basis, “importantly clearing back-orders of new products,” the analyst tells i...

Is InMode (INMD) a Great Value Stock Right Now? — Oct 14th, 2024

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. Looking at t...